Get the Stockscreener App
5.1622
2.16%
-0.0812
Bioharvest Sciences Inc stock is traded at $5.1622, with a volume of 1,948.
It is down -2.16% in the last 24 hours and up +2.82% over the past month.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
See More
Previous Close:
$5.2434
Open:
$5.35
24h Volume:
1,948
Relative Volume:
0.27
Market Cap:
$92.70M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.73%
1M Performance:
+2.82%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$5.01
$5.35
1-Week Range:
$5.00
$5.78
52-Week Range:
$4.7237
$6.85
Bioharvest Sciences Inc Stock (BHST) Company Profile
Name
Bioharvest Sciences Inc
Sector
Industry
Phone
-
Address
-
Compare BHST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
5.2224 | 92.70M | 0 | 0 | 0 | 0.00 |
|
KHC
Kraft Heinz Co
|
31.23 | 37.97B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
61.50 | 33.79B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova
|
82.50 | 28.11B | 12.80B | 1.01B | 927.00M | 2.91 |
|
MKC
Mccormick Co Inc
|
84.43 | 22.35B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.01 | 15.80B | 11.92B | 805.04M | 1.01B | 1.46 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Maxim Group | Buy |
Bioharvest Sciences Inc Stock (BHST) Latest News
BioHarvest Sciences Inc. (NASDAQ:BHST) Not Flying Under The Radar - Simply Wall St
BioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To Profit - Yahoo Finance
BioHarvest Sciences surpasses 50 million dollars in VINIA sales, plans major production expansion - Proactive Investors USA
BioHarvest's VINIA sales top $50M, plans production boost By Investing.com - Investing.com Canada
BioHarvest’s VINIA Achieves $50 Million in Sales, Plans Major Expansion - TipRanks
BioHarvest's VINIA sales top $50M, plans production boost - Investing.com India
BioHarvest’s VINIA sales top $50M, plans production boost By Investing.com - Investing.com Nigeria
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD - Newsfile
BioHarvest Sciences to Delist from CSE, Focuses on Nasdaq - TipRanks
CSE Bulletin: DelistBioHarvest Sciences Inc. (BHSC) - TradingView
BioHarvest CEO to present at WeBull Consumer Stocks Virtual Webinar - Proactive Investors USA
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar - TipRanks
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18 - Newsfile
Exclusive: Inside BioHarvest's Revolutionary Plant-Based TechnologyCEO Reveals Growth Strategy - StockTitan
Bioharvest Sciences to voluntarily delist from CSE - Proactive Investors Australia
BioHarvest Sciences to Delist from CSE, Focus on Nasdaq - TipRanks
When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St
BioHarvest Sciences reports material change - Investing.com India
BioHarvest Sciences Appoints Sharon Malka to Board of Directors - TipRanks
BioHarvest Sciences reports material change By Investing.com - Investing.com UK
BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors UK
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com
OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.
BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors UK
BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia
CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK
BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks
BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com
BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World
Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India
BioHarvest Sciences (NASDAQ:BHST) Now Covered by Maxim Group - MarketBeat
BioHarvest Sciences CEO discusses Tate & Lyle partnershipICYMI - Proactive Investors USA
Clean the SkyBotanical Sweetener Partnerships - Trend Hunter
BioHarvest Sciences shares keep buy rating, partnership drives optimism By Investing.com - Investing.com South Africa
Bioharvest Sciences Inc Stock (BHST) Financials Data
There is no financial data for Bioharvest Sciences Inc (BHST). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.64%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):